Chemotherapy Alone or HSCT After Reduced-Intensity Conditioning for Patients with Malignant Hematologic Diseases Are Not Associated to Metabolic Syndrome: A Cross-Sectional Observational Study

REFERENCES

• Secretaría de Salud, Dirección General de Epidemiología: Compendio de Cáncer 2000: Mortalidad/Morbilidad. Registro Histopatológico de Neoplasias Malignas 2000. Mexico, D. F., Mexico: Secretaría de Salud, Dirección General de Epidemiología, 2001.
   Google Scholar
• Tirado-Gómez LL and Mohar-Betancourt A: Epidemiología de las neoplasias hemato-oncológicas. Cancerología 2, 109–120, 2007.
   Google Scholar
• Pui CH, Pei D, Sandlund JT, Campana D, Ribeiro RC, et al.: Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23, 7936–7941, 2005.
   PubMed Web of Science ®Google Scholar
• Mehta SK, Richards N, Lorber R, and Rosenthal GL.: Abdominal obesity, waist circumference, body mass index, and echocardiographic measures in children and adolescents. Congenit Heart Dis 4, 338–347, 2009.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation: The IDF Consensus Worldwide Definition of Metabolic Syndrome. Retrieved from http://www.idf.org/webdata/docs/MetS_def_update2006.pdf
   Google Scholar
• Reusch JE: Current concepts in insulin resistance, type 2 diabetes mellitus, and the metabolic syndrome. Am J Cardiol 90, 19G–26G, 2002.
   PubMed Web of Science ®Google Scholar
• Iughetti L, Bruzzi P, Predieri B, and Paolucci P: Obesity in patients with acute lymphoblastic leukemia in childhood. Ital J Pediatr 38, 2012. doi:10.1186/1824-7288-38-4
   Google Scholar
• Paredes-Aguilera R: Efectos tardíos del tratamiento antileucémico. Revista de Hematología 11, 4–11, 2010.
   Google Scholar
• Chow EJ, Simmons JH, Roth CL, Baker KS, Hoffmeister PA, et al.: Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. Biol Blood Marrow Transplant 16, 1674–1681, 2010.
   PubMed Web of Science ®Google Scholar
• Mertens AC, Yasui Y, and Neglia JP: Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 19, 3163–3172, 2001.
   PubMed Web of Science ®Google Scholar
• World Health Organization: Physical Status: The Use and Interpretation of Anthropometry: Report of a WHO Expert Committee . (WHO Technical Report Series 854). Geneva, Switzerland: World Health Organization, 1995.
   Google Scholar
• NORMA Oficial Mexicana NOM-008-SSA3-2010: Para el Tratamiento Integral Del Sobrepeso y la Obesidad. . Mexico, D. F., Mexico: Secretaría de Salud, 2010.
   Google Scholar
• Blijdorp K, van Waas M, van der Lely AJ, Pieters R, van den Heuvel-Eibrink M, et al.: Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia. Leukemia Research 37, 367–371, 2013.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al.: Diagnosis and management of the metabolic syndrome. Circulation: Journal of the American Heart Association 112, 2735–2752, 2005.
   Google Scholar
• Alberti KGMM, Zimmet PZ, and Shaw JE: The metabolic syndrome: A new worldwide definition from the International Diabetes Federation Consensus. Lancet 366, 1059–1062, 2013.
   Web of Science ®Google Scholar
• Instituto Nacional de Salud Pública: Encuesta Nacional de Salud y Nutrición 2012. . Retrieved from ensanut.insp.mx/informes/ENSANUT2012ResultadosNacionales.pdf
   Google Scholar
• Gomez-Almaguer D.: The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients. International Journal of Hematology 76, 380–382, 2002.
   PubMed Web of Science ®Google Scholar
• Cantu-Rodriguez OG, Jaime-Pérez JC, Guitiérrez-Aguirre CH, González-Llano O, Mancías-Guerra C, et al.: Outpatient allografting using non-myeloablative conditioning: the Mexican experience. Bone Marrow Transplantation 40, 119–123, 2007.
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, González-Llano O, Cantú-Rodriguez O, et al.: Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimensAmerican Journal of Hematology 66, 241–244, 2001.
   PubMed Web of Science ®Google Scholar
• Oudin C, Simeoni MC, Sirvent N, Contet A, Begu-Le Corroller A, et al.: Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood Journal 117, 4442–4448, 2011.
   PubMed Web of Science ®Google Scholar
• Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, Shamah-Levy T, Rauda J, et al.: Metabolic syndrome in Mexican adults. Results from the National Health and Nutrition Survey 2006. Salud Publica Mex 52, S11–S18, 2010.
   PubMed Web of Science ®Google Scholar
• Wisse BE: The inflammatory syndrome: The role adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 15, 792–800, 2004.
   Web of Science ®Google Scholar
• Andrews RC and Walker BR: Glucocorticoids and insulin resistance: old hormones, new targets. Clinical Science 96, 513–523, 1999.
   PubMed Web of Science ®Google Scholar
• Grundy SM: Metabolic syndrome: Connecting and reconciling cardiovascular and diabetes world. J Am Coll Cardiol 47, 1093–100, 2006.
   PubMed Web of Science ®Google Scholar
• Baker KS, Chow E, and Steinberger J: Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplantation 47, 619–625, 2012.
   PubMed Web of Science ®Google Scholar
• Annaloro C, Airaghi L, Saporiti G, Onida F, Cortelezzi A, et al.: Metabolic syndrome in patients with hematological diseases. Expert Rev Hematol. 5, 439–458, 2012
   PubMed Web of Science ®Google Scholar
• Taskinen M, Saarinen-Pihkala UM, Hovi L, and Lipsanen-Nyman M.: Impaired glucose tolerance and dyslipidaemia as late effects after bone- marrow transplantation in childhood. Lancet 356, 993–997, 2000.
   PubMed Web of Science ®Google Scholar
• Baker KS, Ness KK, Steinberger J, Carter A, Francisco L, et al.: Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study. Blood 109, 1765–1772, 2007.
   PubMed Web of Science ®Google Scholar
• Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, et al.: High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 43, 49–54, 2009.
   PubMed Web of Science ®Google Scholar
• Gurney JG, Ness KK, Sibley SD, O’Leary M, Dengel DR, et al.: Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer 107, 1303–1312, 2006
   PubMed Web of Science ®Google Scholar
• Jaime-Pérez JC, Colunga-Pedraza PR, Gutiérrez-Gurrola B, Brito-Ramírez AS, Gutiérrez-Aguirre H, et al. Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant. Blood Cells Mol Dis. 51, 61–65 2013.
   PubMed Web of Science ®Google Scholar